Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Pulmonary Hypertension 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Pulmonary Hypertension 25
Subjects Recruited Over a Period of Time 31
Prominent Sponsors 32
Top Companies Participating in Pulmonary Hypertension Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Actelion Ltd 37
Clinical Trial Overview of Actelion Ltd 37
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
United Therapeutics Corporation 43
Clinical Trial Overview of United Therapeutics Corporation 43
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
Gilead Sciences, Inc. 47
Clinical Trial Overview of Gilead Sciences, Inc. 47
GlaxoSmithKline plc 48
Clinical Trial Overview of GlaxoSmithKline plc 48
Novartis AG 49
Clinical Trial Overview of Novartis AG 49
Eli Lilly and Company 50
Clinical Trial Overview of Eli Lilly and Company 50
Lung Rx, Inc. 51
Clinical Trial Overview of Lung Rx, Inc. 51
INO Therapeutics, LLC 52
Clinical Trial Overview of INO Therapeutics, LLC 52
AstraZeneca PLC 53
Clinical Trial Overview of AstraZeneca PLC 53
EPIX Pharmaceuticals, Inc. (Inactive) 54
Clinical Trial Overview of EPIX Pharmaceuticals, Inc. (Inactive) 54
Nippon Shinyaku Co., Ltd. 55
Clinical Trial Overview of Nippon Shinyaku Co., Ltd. 55
GENO Pharmaceuticals Ltd. 56
Clinical Trial Overview of GENO Pharmaceuticals Ltd. 56
Encysive Pharmaceuticals Inc. 57
Clinical Trial Overview of Encysive Pharmaceuticals Inc. 57
Berlin Chemi AG 58
Clinical Trial Overview of Berlin Chemi AG 58
Children's Healthcare of Atlanta Inc. 59
Clinical Trial Overview of Children's Healthcare of Atlanta Inc. 59
Medtronic Cardiac Rhythm Disease Management 60
Clinical Trial Overview of Medtronic Cardiac Rhythm Disease Management 60
Clinical Trial Overview of Top Universities / Institutes / Hospitals 61
University of Heidelberg 61
Clinical Trial Overview of University of Heidelberg 61
Keio University 62
Clinical Trial Overview of Keio University 62
Assistance Publique - Hopitaux de Paris 63
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 63
University of California, Los Angeles 64
Clinical Trial Overview of University of California, Los Angeles 64
The Medical University of Graz 65
Clinical Trial Overview of The Medical University of Graz 65
The University of Chicago 66
Clinical Trial Overview of The University of Chicago 66
North Shore Long Island Jewish Health System 67
Clinical Trial Overview of North Shore Long Island Jewish Health System 67
University of Cincinnati 68
Clinical Trial Overview of University of Cincinnati 68
The Cleveland Clinic 69
Clinical Trial Overview of The Cleveland Clinic 69
Rabin Medical Center 70
Clinical Trial Overview of Rabin Medical Center 70
University of Oxford 71
Clinical Trial Overview of University of Oxford 71
Medical University of Vienna 72
Clinical Trial Overview of Medical University of Vienna 72
Imperial College London 73
Clinical Trial Overview of Imperial College London 73
The Children's Hospital of Philadelphia 74
Clinical Trial Overview of The Children's Hospital of Philadelphia 74
Aarhus University 75
Clinical Trial Overview of Aarhus University 75
Mayo Clinic 76
Clinical Trial Overview of Mayo Clinic 76
Duke University 77
Clinical Trial Overview of Duke University 77
University of California, San Francisco 78
Clinical Trial Overview of University of California, San Francisco 78
Radboud University 79
Clinical Trial Overview of Radboud University 79
Department of Defence 80
Clinical Trial Overview of Department of Defence 80
Five Key Clinical Profiles 81
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 119
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120
List of Tables
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15
Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Pulmonary Hypertension Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Pulmonary Hypertension Therapeutics Clinical Trials, G7 Countries, 2012* 18
Pulmonary Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Pulmonary Hypertension Therapeutics Clinical Trials, E7 Countries, 2012* 20
Pulmonary Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Pulmonary Hypertension Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Pulmonary Hypertension Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Pulmonary Hypertension Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 33
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 35
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2012* 37
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 40
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2012* 43
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 45
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012* 47
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 48
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 49
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 50
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Lung Rx, Inc., 2012* 51
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by INO Therapeutics, LLC, 2012* 52
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 53
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by EPIX Pharmaceuticals, Inc. (Inactive), 2012* 54
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Nippon Shinyaku Co., Ltd., 2012* 55
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by GENO Pharmaceuticals Ltd., 2012* 56
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Encysive Pharmaceuticals Inc., 2012* 57
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Berlin Chemi AG, 2012* 58
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Healthcare of Atlanta Inc., 2012* 59
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic Cardiac Rhythm Disease Management, 2012* 60
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2012* 61
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2012* 62
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 63
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 64
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medical University of Graz, 2012* 65
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012* 66
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore Long Island Jewish Health System, 2012* 67
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cincinnati, 2012* 68
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 69
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2012* 70
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012* 71
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 72
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 73
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2012* 74
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012* 75
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 76
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 77
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 78
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 79
Pulmonary Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Defence, 2012* 80
List of Figures
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Pulmonary Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Pulmonary Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Pulmonary Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Pulmonary Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15
Pulmonary Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
Pulmonary Hypertension Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Pulmonary Hypertension Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Pulmonary Hypertension Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Pulmonary Hypertension Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Pulmonary Hypertension Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Pulmonary Hypertension Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 31
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 32
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 34
Pulmonary Hypertension Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 36
GlobalData Methodology 118